Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from A Bispecific Biologic That Robustly Reverses HIV-1 and SIV Latency. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1126/science.278.5341.1295
10.1126/science.278.5341.1295 · External reference
10.1073/pnas.94.24.13193
10.1073/pnas.94.24.13193 · External reference
10.1038/nm.3489
10.1038/nm.3489 · External reference
10.1038/nature11286
10.1038/nature11286 · External reference
Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial
10.1016/s2352-3018(14)70014-1 · 2014 · External reference
The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo
10.1371/journal.ppat.1005142 · 2015 · External reference
10.1038/s41586-020-1946-0
10.1038/s41586-020-1946-0 · External reference
10.1038/s41586-020-1951-3
10.1038/s41586-020-1951-3 · External reference
10.1126/sciadv.aea4268
10.1126/sciadv.aea4268 · External reference
10.1126/science.1187659
10.1126/science.1187659 · External reference
10.1126/science.1207227
10.1126/science.1207227 · External reference
10.1016/j.cell.2014.07.043
10.1016/j.cell.2014.07.043 · External reference
10.1016/j.cell.2016.05.024
10.1016/j.cell.2016.05.024 · External reference
Correlates of HIV-1 control after combination immunotherapy
10.1038/s41586-025-09929-5 · 2026 · External reference
CD8+ T cell stemness precedes post-intervention control of HIV viraemia
10.1038/s41586-025-09932-w · 2026 · External reference
10.1016/j.bbih.2023.100029
10.1016/j.bbih.2023.100029 · External reference
10.1038/s44386-025-00025-2 · 2025 · Admitted local publication
10.1126/science.abe1707
10.1126/science.abe1707 · External reference
10.1016/j.cell.2024.01.048
10.1016/j.cell.2024.01.048 · External reference
10.1038/ncomms11291
10.1038/ncomms11291 · External reference
IL-15 enhances HIV-1 infection by promoting survival and proliferation of CCR5+CD4+ T cells
10.1172/jci.insight.166292 · 2023 · External reference
Activation of naive and memory T cells by interleukin-15
10.1182/blood.v88.1.230.230 · 1996 · External reference
10.1093/nar/gkr1224
10.1093/nar/gkr1224 · External reference
Discovery of a novel IL-15 based protein with improved developability and efficacy for cancer immunotherapy
10.1038/s41598-018-25987-4 · 2018 · External reference
10.1126/science.adf7966
10.1126/science.adf7966 · External reference
10.1038/s41591-021-01651-9
10.1038/s41591-021-01651-9 · External reference
Unresolved reference
External reference
10.1056/nejmoa1711460
10.1056/nejmoa1711460 · External reference
10.1016/j.str.2010.09.017
10.1016/j.str.2010.09.017 · External reference
10.1186/s12977-018-0439-9
10.1186/s12977-018-0439-9 · External reference
Bispecific 10E8.4/iMab broadly neutralizing antibody in people with or without HIV-1: a partially randomized phase 1 trial
10.1038/s41591-026-04472-w · 2026 · External reference
10.1172/jci80142
10.1172/jci80142 · External reference
10.1128/jvi.00609-14
10.1128/jvi.00609-14 · External reference
10.1016/j.immuni.2023.03.010
10.1016/j.immuni.2023.03.010 · External reference
HIV DNA Set Point is Rapidly Established in Acute HIV Infection and Dramatically Reduced by Early ART
10.1016/j.ebiom.2016.07.024 · 2016 · External reference
SEARCH011 study groups, Abundant HIV-infected cells in blood and tissues are rapidly cleared upon ART initiation during acute HIV infection
10.1126/scitranslmed.aav3491 · 2020 · External reference
10.1073/pnas.1302634110
10.1073/pnas.1302634110 · External reference
Correlations among quantitative assays that measure the size of HIV reservoirs in people with HIV receiving antiretroviral therapy
10.1097/qad.0000000000004297 · 2025 · External reference
10.1073/pnas.2008190117
10.1073/pnas.2008190117 · External reference
10.1126/science.adk1831
10.1126/science.adk1831 · External reference
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
10.1371/journal.ppat.1005545 · 2016 · External reference
10.1073/pnas.1302634110
10.1073/pnas.1302634110 · External reference
10.1038/ni.2449
10.1038/ni.2449 · External reference
10.1038/nature11604
10.1038/nature11604 · External reference
10.1084/jem.20070567
10.1084/jem.20070567 · External reference
10.1084/jem.20090356
10.1084/jem.20090356 · External reference
10.1084/jem.20112071
10.1084/jem.20112071 · External reference
Keele, Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy
10.1371/journal.ppat.1006359 · 2017 · External reference
10.1038/s41591-018-0130-7
10.1038/s41591-018-0130-7 · External reference
Initial sites of SIV rebound after antiretroviral treatment cessation in rhesus macaques
10.1038/s41564-025-02258-3 · 2026 · External reference
